Neutrophils Induce a Novel Chemokine Receptors Repertoire During Influenza Pneumonia.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN: 2235-2988 (Electronic) Linking ISSN: 22352988 NLM ISO Abbreviation: Front Cell Infect Microbiol Subsets: MEDLINE
    • Publication Information:
      Original Publication: Lausanne : Frontiers Media SA
    • Subject Terms:
    • Abstract:
      Exaggerated host innate immune responses have been implicated in severe influenza pneumonia. We have previously demonstrated that excessive neutrophils recruited during influenza infection drive pulmonary pathology through induction of neutrophil extracellular traps (NETs) and release of extracellular histones. Chemokine receptors (CRs) are essential in the recruitment and activation of leukocytes. Although neutrophils have been implicated in influenza pathogenesis, little is known about their phenotypic changes, including expression of CRs occurring in the infected -lung microenvironment. Here, we examined CC and CXC CRs detection in circulating as well as lung-recruited neutrophils during influenza infection in mice using flow cytometry analyses. Our studies revealed that lung-recruited neutrophils displayed induction of CRs, including CCR1, CCR2, CCR3, CCR5, CXCR1, CXCR3, and CXCR4, all of which were marginally induced in circulating neutrophils. CXCR2 was the most predominant CR observed in both circulating and lung-infiltrated neutrophils after infection. The stimulation of these induced CRs modulated neutrophil phagocytic activity, ligand-specific neutrophil migration, bacterial killing, and NETs induction ex vivo . These findings indicate that neutrophils induce a novel CR repertoire in the infectious lung microenvironment, which alters their functionality during influenza pneumonia.
    • References:
      Am J Pathol. 2011 Jul;179(1):199-210. (PMID: 21703402)
      Front Immunol. 2013 Mar 05;4:56. (PMID: 23467809)
      Nature. 2013 May 23;497(7450):498-502. (PMID: 23636320)
      Am J Pathol. 2004 Dec;165(6):2187-96. (PMID: 15579460)
      J Immunol. 2009 Oct 15;183(8):5301-10. (PMID: 19783685)
      Lancet Infect Dis. 2014 Jan;14(1):57-69. (PMID: 24239327)
      Annu Rev Immunol. 2000;18:593-620. (PMID: 10837070)
      Am J Respir Cell Mol Biol. 2010 Jun;42(6):732-43. (PMID: 19617401)
      Virology. 2016 Dec;499:23-29. (PMID: 27632562)
      Annu Rev Pathol. 2008;3:499-522. (PMID: 18039138)
      Front Immunol. 2017 Dec 13;8:1799. (PMID: 29326698)
      Am J Respir Cell Mol Biol. 2018 Apr;58(4):492-499. (PMID: 29141155)
      Intern Med. 2010;49(5):427-30. (PMID: 20190477)
      Nat Rev Immunol. 2014 May;14(5):315-28. (PMID: 24762827)
      Am J Pathol. 2018 Jan;188(1):135-148. (PMID: 29107075)
      Exp Mol Pathol. 2012 Jun;92(3):287-95. (PMID: 22421441)
      Trends Immunol. 2004 Feb;25(2):75-84. (PMID: 15102366)
      PLoS Pathog. 2008 Aug 01;4(8):e1000115. (PMID: 18670648)
      Eur J Immunol. 2008 Dec;38(12):3376-87. (PMID: 19039768)
      JCI Insight. 2018 Dec 20;3(24):. (PMID: 30568032)
      BMC Infect Dis. 2016 Oct 3;16(1):534. (PMID: 27716101)
      Curr Top Microbiol Immunol. 2015;386:23-71. (PMID: 25078919)
      J Leukoc Biol. 2015 Mar;97(3):447-54. (PMID: 25412626)
      Proc Natl Acad Sci U S A. 2014 Mar 11;111(10):3799-804. (PMID: 24572573)
      Viral Immunol. 2007 Sep;20(3):369-78. (PMID: 17931107)
      Interdiscip Perspect Infect Dis. 2011;2011:146376. (PMID: 21747847)
      Am J Respir Crit Care Med. 2010 Jan 1;181(1):72-9. (PMID: 19875682)
      J Clin Invest. 1982 Jun;69(6):1393-7. (PMID: 7085879)
      Influenza Other Respir Viruses. 2013 May;7(3):472-9. (PMID: 22862736)
      Nat Med. 2006 Oct;12(10):1203-7. (PMID: 16964257)
      PLoS Pathog. 2016 Jul 20;12(7):e1005754. (PMID: 27438481)
      PLoS One. 2011;6(7):e21772. (PMID: 21747955)
      mBio. 2011 Sep 20;2(5):. (PMID: 21933918)
      Immunity. 2010 Aug 27;33(2):266-78. (PMID: 20727790)
      Blood. 2008 Sep 1;112(5):2028-34. (PMID: 18544685)
      Oncotarget. 2016 Apr 12;7(15):19327-40. (PMID: 27034012)
      Am J Respir Crit Care Med. 2006 Nov 1;174(9):1011-7. (PMID: 16917113)
      J Immunol. 2007 Feb 15;178(4):2448-57. (PMID: 17277152)
      J Immunol. 2014 Apr 1;192(7):3301-7. (PMID: 24563256)
      Blood. 2006 Dec 15;108(13):4205-13. (PMID: 16931627)
      mSphere. 2018 Jan 3;3(1):. (PMID: 29299535)
      Funct Integr Genomics. 2012 Mar;12(1):105-17. (PMID: 21874528)
      Semin Immunopathol. 2017 Jul;39(5):541-550. (PMID: 28555383)
      J Immunol. 2008 Dec 1;181(11):8053-67. (PMID: 19017998)
      Cell Mol Immunol. 2016 Jan;13(1):3-10. (PMID: 26189369)
      Nat Immunol. 2001 Feb;2(2):123-8. (PMID: 11175804)
      Scand J Infect Dis. 2008;40(4):326-37. (PMID: 17918019)
      Annu Rev Immunol. 2000;18:217-42. (PMID: 10837058)
      Nature. 2004 Oct 7;431(7009):703-7. (PMID: 15470432)
      Science. 2005 Oct 7;310(5745):77-80. (PMID: 16210530)
      J Leukoc Biol. 2003 Aug;74(2):252-9. (PMID: 12885942)
    • Grant Information:
      P20 GM103648 United States GM NIGMS NIH HHS
    • Contributed Indexing:
      Keywords: acute lung injury; chemokine receptor; influenza; mouse model; neutrophil
    • Accession Number:
      0 (Receptors, Chemokine)
    • Publication Date:
      Date Created: 20190502 Date Completed: 20191209 Latest Revision: 20200309
    • Publication Date:
      20240829
    • Accession Number:
      PMC6476945
    • Accession Number:
      10.3389/fcimb.2019.00108
    • Accession Number:
      31041196